Patent application number | Description | Published |
20090012167 | Omega-3 Fatty Acids and Dyslipidemic Agent for Lipid Therapy - A method and composition for blood lipid therapy by administering to the subject an effective amount of a dyslipidemic agent and omega-3 fatty acids. The method utilizes a single administration or a unit dosage of a combination of dyslipidemic agent and omega-3 fatty acids for the treatment of patients with hypertriglyceridemia, hypercholesterolemia, mixed dyslipidemia, coronary heart disease (CHD), vascular disease, artherosclerotic disease and related conditions, and the prevention or reduction of cardiovascular and vascular events. | 01-08-2009 |
20090239927 | Statin and Omega-3 Fatty Acids For Lipid Therapy - A method of lipid therapy, comprising providing a subject group having a baseline triglyceride level of 200 to 499 mg/dl and being at or near its low-density lipoprotein cholesterol (LDL-C) level goal, and reducing the triglyceride level and the non-high-density lipoprotein cholesterol (non-HDL-C) level of the subject group as compared to treatment with a 3-hydroxy-3-methyl glutaryl coenzyme A (HMG CoA) inhibitor alone, by administering to the subject group an effective amount of an HMG CoA inhibitor and a composition comprising omega-3 fatty acids. | 09-24-2009 |
20110092563 | STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY - A method of lipid therapy, comprising providing a subject group having a baseline triglyceride level of 200 to 499 mg/dl and being at or near its low-density lipoprotein cholesterol (LDL-C) level goal, and reducing the triglyceride level and the non-high-density lipoprotein cholesterol (non-HDL-C) level of the subject group as compared to treatment with a 3-hydroxy-3-methyl glutaryl coenzyme A (HMG CoA) inhibitor alone, by administering to the subject group an effective amount of an HMG CoA inhibitor and a composition comprising omega-3 fatty acids. | 04-21-2011 |
20110104297 | METHODS OF USING KRILL OIL TO TREAT RISK FACTORS FOR CARDIOVASCULAR, METABOLIC, AND INFLAMMATORY DISORDERS - This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondrial respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. | 05-05-2011 |
20140080889 | Statin and Omega-3 Fatty Acids for Lipid Therapy - A method and composition for lipid therapy. In some embodiments, the method comprises providing a subject group having a baseline triglyceride level of 200 to 499 mg/dl and being at or near its low-density lipoprotein cholesterol (LDL-C) level goal, and reducing the triglyceride level and the non-high-density lipoprotein cholesterol (non-HDL-C) level of the subject group as compared to treatment with a 3-hydroxy-3-methyl glutaryl coenzyme A (HMG CoA) inhibitor alone, by administering to the subject group an effective amount of an HMG CoA inhibitor and a composition comprising omega-3 fatty acids. | 03-20-2014 |
20140363517 | METHODS OF USING KRILL OIL TO TREAT RISK FACTORS FOR CARDIOVASCULAR, METABOLIC, AND INFLAMMATORY DISORDERS - This invention discloses methods of using krill oil and compositions comprising krill oil to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. The present invention also relates to methods of using compositions comprising krill oil to modulate biological processes selected from the group consisting of glucose metabolism, lipid biosynthesis, fatty acid metabolism, cholesterol biosynthesis, and the mitochondria respiratory chain. The present invention further includes pharmaceutical and/or nutraceutical formulations made from krill oil, methods of making such formulations, and methods of administering them to treat risk factors for metabolic, cardiovascular, and inflammatory disorders. | 12-11-2014 |
Patent application number | Description | Published |
20110106776 | INCREMENTAL IMPLEMENTATION OF UNDO/REDO SUPPORT IN LEGACY APPLICATIONS - Systems and methods are described for incremental implementation of undo\redo support in legacy applications. In one implementation, a system enables a per-object undo/redo process to be realized in pre-existing computer programs that have limited or no undo/redo functionality, while minimizing changes to such pre-existing computer programs. An innovative process stores an undo/redo instruction for each user-initiated operation in a data structure, classifies each undo/redo instruction under one or more objects affected by the operation, or vice/versa, and verifies the validity of each undo/redo instruction before performing an undo/redo. In one implementation, the process stores only undo/redo instructions in the data structure for those operations that can be validated beforehand as being undoable/redoable. Various data structure schemes are available, each of which may increase performance while implementing the undo-redo support for a given legacy software, e.g., by increasing speed and/or decreasing data size, memory consumption, disk consumption, power consumption, and so forth. The ability to validate undoability/redoability before performing an undo/redo operation gives the architecture versatility for updating many different applications. | 05-05-2011 |
20110107246 | UNDO/REDO OPERATIONS FOR MULTI-OBJECT DATA - Innovative undo/redo operations can be applied to separate objects or parts of objects within multi-object data, without having to undo and redo along a rigid chronological sequence of recorded operations. In one implementation, a user selects an object, or part of an object, and innovative undo/redo techniques enable the user to apply undo and redo operations to only the selected object or part, while skipping undo and redo operations for other objects. The undo/redo operations can also be applied in parallel to multiple objects. A graphical user interface (GUI) provides linear or hierarchical representations of operations applied to each object and displays undo/redo controls for each object. | 05-05-2011 |